A carregar...
NOVEL PROTEIN THERAPEUTICS FOR SYSTOLIC HEART FAILURE: CHRONIC SUBCUTANEOUS BNP
OBJECTIVES: The objective of the present study was to translate our laboratory investigations to establish safety and efficacy of 8 weeks of chronic SQ BNP administration in human Stage C HF. BACKGROUND: B-Type natriuretic peptide (BNP) is a cardiac hormone with vasodilating, natriuretic, renin-angi...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3555560/ https://ncbi.nlm.nih.gov/pubmed/23122795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jacc.2012.07.056 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|